Sufeng Zhou
China Pharmaceutical University
8 Papers
112 Citations
Sufeng Zhou is an academic researcher from China Pharmaceutical University. The author has contributed to research in topics: Pharmacokinetics & Active metabolite. The author has an hindex of 6, co-authored 8 publications.
Chat about Author
Papers
Pharmacokinetics and pharmacodynamics evaluation of a thermosensitive chitosan based hydrogel containing liposomal doxorubicin.
Shuangxia Ren,Yu Dai,Cuiyun Li,Zhixia Qiu,Xin Wang,Fengjie Tian,Sufeng Zhou,Qi Liu,Han Xing,Yang Lu,Xijing Chen,Ning Li +11 more
TL;DR: In vitro and in vivo antitumor experiments demonstrated that LipDOX+C/GP group had better antineoplastic effect and less toxicity thandoxorubicin group, and the novel thermosensitive hydrogel formulation was potential for clinical application in cancer treatment.
43
Pharmacokinetics and biodistribution study of paclitaxel liposome in Sprague-Dawley rats and Beagle dogs by liquid chromatography-tandem mass spectrometry.
Xinting Wang,Ling Song,Ning Li,Zhixia Qiu,Sufeng Zhou,Cuiyun Li,Jie Zhao,H. Song,Xijing Chen +8 more
TL;DR: Biodistribution results in rats showed that except for brain and testis, liposomal paclitaxel was extensively distributed into various tissues, especially highly in liver and spleen.
30
Efficacy, pharmacokinetics, and biodistribution of thermosensitive chitosan/β-glycerophosphate hydrogel loaded with docetaxel.
Cuiyun Li,Shuangxia Ren,Yu Dai,Fengjie Tian,Xin Wang,Sufeng Zhou,Shuhua Deng,Qi Liu,Jie Zhao,Xijing Chen +9 more
TL;DR: In conclusion, DTX-C/GP demonstrated controlled release and significant efficacy and exhibited potential for further clinical development.
Species Comparison of Pre-systemic Bioactivation of Vicagrel, a New Acetate Derivative of Clopidogrel
TL;DR: The unconformity of AM and CAM exposure cross species mainly came from the metabolism of 2-oxo-clopidogrel associated largely with tissue specificity and interspecies differences of esterases.
Pharmacokinetic evaluation of β-caryophyllene alcohol in rats and beagle dogs.
TL;DR: This was the first preclinical pharmacokinetic investigation of BCPA in animals, providing vital knowledge for further preclinical research and subsequent clinical trials.
6